Related Experiment Videos

Hypoglycemia in small-for-gestational-age neonates'

O Karahasanoğlu1, G Karatekin, R Köse

  • 1Pediatric Clinics, Sişli Etfal Hospital, Istanbul.

Insights

Hypoglycemia screening in small-for-gestational-age (SGA) neonates is crucial. This study found SGA infants have higher hypoglycemia rates, recommending continued screening for 48 hours postnatally.

Area of Science:

  • Neonatal Medicine
  • Pediatric Endocrinology
  • Clinical Chemistry

Background:

  • Neonatal hypoglycemia is a common concern, particularly in small-for-gestational-age (SGA) infants.
  • Early detection and management are vital to prevent adverse neurodevelopmental outcomes.

Purpose of the Study:

  • To determine the frequency of hypoglycemia in SGA neonates.
  • To establish optimal screening intervals for hypoglycemia in this population.

Main Methods:

  • Prospective study involving 25 SGA and 16 appropriate-for-gestational-age (AGA) neonates born after 37 weeks gestation.
  • Blood glucose levels measured using test-strips at 2, 3, 6, 12, 24, and 48 hours of age.
  • Serum glucose confirmation for values below 40 mg/dl.

Main Results:

  • SGA neonates exhibited a significantly higher frequency of hypoglycemia compared to AGA neonates (p:0.097).
  • Hypoglycemia was most frequently detected within the first three hours, at the sixth hour, and at 48 hours postnatally.
  • Clinical signs were unreliable indicators of hypoglycemia.

Conclusions:

  • Hypoglycemia screening in SGA neonates should extend up to 48 hours postnatally.
  • Routine monitoring is essential, as clinical signs alone are insufficient for diagnosis.
  • This supports evidence-based guidelines for neonatal hypoglycemia management.

Related Concept Videos